Literature DB >> 15617772

Trace fear conditioning depends on NMDA receptor activation and protein synthesis within the dorsal hippocampus of mice.

Klaus Wanisch1, Jianrong Tang, Anna Mederer, Carsten T Wotjak.   

Abstract

Various lesion studies demonstrated that trace but not delay fear conditioning requires an intact hippocampal formation. Our present study examined the role of NMDA receptor activation and protein synthesis within the dorsal hippocampus for acquisition of fear memories following trace (5-s trace) and delay conditioning. To this end male C57BL/6JOlaHsd mice were chronically implanted with guide cannulae targeting the dorsal hippocampus. Fifteen minutes before conditioning mice received a bilateral intrahippocampal injection of either the NMDA receptor antagonist AP5 (0.5 or 1 microg per 0.5 microl per side) or of anisomycin, an inhibitor of protein synthesis (62.5 microg per 0.5 microl per side). Control mice were treated with vehicle (Ringer's solution). Blocking NMDA receptors before trace but not delay conditioning dose-dependently attenuated the freezing response to the tone as assessed 24 h after conditioning. The same findings were obtained after blocking protein synthesis within the dorsal hippocampus. These data indicate that the hippocampus shows synaptic plasticity during trace conditioning that requires an activation of NMDA receptors and protein synthesis as prerequisites for the acquisition of fear memory.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15617772     DOI: 10.1016/j.bbr.2004.06.009

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  17 in total

1.  Differential acetylcholine release in the prefrontal cortex and hippocampus during pavlovian trace and delay conditioning.

Authors:  M Melissa Flesher; Allen E Butt; Brandee L Kinney-Hurd
Journal:  Neurobiol Learn Mem       Date:  2011-04-15       Impact factor: 2.877

2.  Trace and contextual fear conditioning require neural activity and NMDA receptor-dependent transmission in the medial prefrontal cortex.

Authors:  Marieke R Gilmartin; Fred J Helmstetter
Journal:  Learn Mem       Date:  2010-05-26       Impact factor: 2.460

Review 3.  Towards a unified model of pavlovian conditioning: short review of trace conditioning models.

Authors:  V I Kryukov
Journal:  Cogn Neurodyn       Date:  2012-02-22       Impact factor: 5.082

4.  Trace fear conditioning in mice.

Authors:  Joaquin N Lugo; Gregory D Smith; Andrew J Holley
Journal:  J Vis Exp       Date:  2014-03-20       Impact factor: 1.355

Review 5.  Prefrontal cortical regulation of fear learning.

Authors:  Marieke R Gilmartin; Nicholas L Balderston; Fred J Helmstetter
Journal:  Trends Neurosci       Date:  2014-06-11       Impact factor: 13.837

6.  The neuropeptide VGF produces antidepressant-like behavioral effects and enhances proliferation in the hippocampus.

Authors:  Smita Thakker-Varia; Jennifer Jernstedt Krol; Jacob Nettleton; Parizad M Bilimoria; Debra A Bangasser; Tracey J Shors; Ira B Black; Janet Alder
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

7.  Genetic background differences and nonassociative effects in mouse trace fear conditioning.

Authors:  Dani R Smith; Michela Gallagher; Mark E Stanton
Journal:  Learn Mem       Date:  2007-09-05       Impact factor: 2.460

8.  Nicotine withdrawal-induced deficits in trace fear conditioning in C57BL/6 mice--a role for high-affinity beta2 subunit-containing nicotinic acetylcholine receptors.

Authors:  J D Raybuck; T J Gould
Journal:  Eur J Neurosci       Date:  2009-01       Impact factor: 3.386

9.  Developing and validating trace fear conditioning protocols in C57BL/6 mice.

Authors:  Michael A Burman; Cassandra A Simmons; Miles Hughes; Lei Lei
Journal:  J Neurosci Methods       Date:  2013-11-20       Impact factor: 2.390

10.  Post-training dephosphorylation of eEF-2 promotes protein synthesis for memory consolidation.

Authors:  Heh-In Im; Akira Nakajima; Bo Gong; Xiaoli Xiong; Takayoshi Mamiya; Elliot S Gershon; Min Zhuo; Ya-Ping Tang
Journal:  PLoS One       Date:  2009-10-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.